Publicacions en col·laboració amb investigadors/es de Hospital Virgen de la Arrixaca (150)

2024

  1. A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 10, Núm. 4, pp. 285-293

  2. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

    European heart journal, Vol. 45, Núm. 16, pp. 1443-1454

  3. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study

    Journal of Clinical Medicine, Vol. 13, Núm. 8

  4. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

    European Heart Journal, Vol. 45, Núm. 28, pp. 2548-2569

  5. Functional Significance in Spontaneous Recanalization of a Coronary Thrombus

    JACC: Case Reports, Vol. 29, Núm. 16

  6. In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease

    Revista Espanola de Cardiologia

  7. Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

    Europace, Vol. 26, Núm. 4

  8. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404

  9. Screening for heart disease in kids and adolescents (Prevencar Program)

    Atencion Primaria, Vol. 56, Núm. 2

  10. Septal Ablation to Treat Subaortic Dynamic Obstruction Following Transcatheter Aortic Valve Implantation

    Journal of the American College of Cardiology, Vol. 84, Núm. 4, pp. 411-415

2023

  1. Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation

    International Journal of Cardiology, Vol. 383, pp. 8-14

  2. An Embedding Approach for Biomarker Identification in Hypertrophic Cardiomyopathy

    Computing in Cardiology

  3. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  4. Current therapies for hypertrophic cardiomyopathy: a systematic review and meta-analysis of the literature

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 8-23

  5. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking

    Frontiers in Cardiovascular Medicine, Vol. 10

  6. High-Dimensional Feature Characterization of Single Nucleotide Variants in Hypertrophic Cardiomyopathy

    Computing in Cardiology

  7. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 301-311

  8. The Novel Variant NP_00454563.2 (p.Glu259Glyfs*77) in Gene PKP2 Associated with Arrhythmogenic Cardiomyopathy in 8 Families from Malaga, Spain

    Genes, Vol. 14, Núm. 7

  9. The Spanish Fabry women study: a retrospective observational study describing the phenotype of females with GLA variants

    Orphanet journal of rare diseases, Vol. 18, Núm. 1, pp. 8

2022

  1. Acute Myocarditis Associated With Desmosomal Gene Variants

    JACC: Heart Failure, Vol. 10, Núm. 10, pp. 714-727